GT
ACHV icon

Glenmede Trust’s Achieve Life Sciences ACHV Stock Holding History

Glenmede Trust’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Hold
0
– – – 2643
2015
Q3 		– Hold
0
– – – 2701
2015
Q2 		– Hold
0
– – – 2672
2015
Q1 		– Hold
0
– – – 2437
2014
Q4 		– Hold
0
– -$1K – 2517
2014
Q3 		– Hold
0
– – – 2382
2014
Q2 		– Hold
0
– – – 2273
2014
Q1 		– Hold
0
– – – 2181
2013
Q4 		– Sell
-1
Closed -$17.5K – 2183
2013
Q3 		$10K Hold
1
– – ﹤0.01% 1923
2013
Q2 		$10K Buy
+1
New +$22.4K ﹤0.01% 1868

Other funds holding ACHV

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
EGA
Eagle Global Advisors Houston, Texas $2.78B AUM 26.09% 1-Year Est. Return
AIM
Alambic Investment Management Belvedere, California $9.12M AUM 34.54% 1-Year Est. Return

Glenmede Trust's ACHV Position: Q4 2015 in Review

Glenmede Trust held its Achieve Life Sciences (ACHV) position steady in Q4 2015 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2643.

Glenmede Trust first reported a position in ACHV in Q2 2013 and has held it in 2 quarters since. The position peaked at $10K in Q3 2013. 47 funds tracked by Wall St. Rank hold ACHV as of Q4 2015.

  • Glenmede Trust held 0 shares of Achieve Life Sciences worth $0 as of Q4 2015.
  • Glenmede Trust left its Achieve Life Sciences share count unchanged in Q4 2015.
  • Achieve Life Sciences made up ﹤0.01% of Glenmede Trust's portfolio in Q4 2015, its #2643 holding.
  • Glenmede Trust first reported a position in Achieve Life Sciences in Q2 2013 and has held it in 2 quarters since.
  • Glenmede Trust's Achieve Life Sciences position peaked at $10K in Q3 2013.
  • 47 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q4 2015.

Based on Glenmede Trust's 13F filing for Q4 2015, filed 11 Feb 2016.